Processa Pharmaceuticals, Inc. - Quarter Report: 2015 March (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2015
or
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____ to ____
Commission File Number 333-184948
Heatwurx, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 45-1539785 |
(State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.) |
18001 S. Figueroa, Unit F
Gardena, CA 90248
(Address of principal executive offices and Zip Code)
(310) 324-4513
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) YES [X] NO [ ]
Indicate by check mark whether the registrant has been subject to such filing requirements for the past 90 days.
YES [ ] NO [X]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES [X] NO [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer, and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer [ ] | Accelerated filer [ ] |
Non-accelerated filer [ ] | Smaller reporting company [X] |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
YES [ ] NO [X]
The registrant has 11,061,114 shares of common stock outstanding as of May 14, 2015.
HEATWURX, INC.
FORM 10-Q
For the Quarter Ended March 31, 2015
TABLE OF CONTENTS
2
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
HEATWURX, INC.
CONSOLIDATED BALANCE SHEETS
| March 31, 2015 |
| December 31, | ||
| (unaudited) |
| 2014 | ||
ASSETS |
|
|
| ||
CURRENT ASSETS: |
|
|
| ||
Cash and cash equivalents | $ | 41,783 |
| $ | 21,234 |
Accounts receivable |
| 5,150 |
|
| 4,095 |
Prepaid expenses and other current assets |
| 42,428 |
|
| 131,862 |
Inventory |
| 197,129 |
|
| 222,018 |
Consigned inventory |
| 124,448 |
|
|
|
Note receivable |
| 86,214 |
|
| - |
Total current assets |
| 497,152 |
|
| 379,209 |
EQUIPMENT, net of depreciation |
| 438,723 |
|
| 466,413 |
INTANGIBLE ASSETS, net of amortization |
| 1,607,145 |
|
| 1,696,430 |
TOTAL ASSETS | $ | 2,543,020 |
| $ | 2,542,052 |
LIABILITIES AND STOCKHOLDERS EQUITY |
|
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
|
Accounts payable | $ | 177,653 |
| $ | 190,168 |
Accrued liabilities |
| 80,838 |
|
| 105,613 |
Deferred revenue |
| 143,129 |
|
| 58,165 |
Interest payable |
| 28,418 |
|
| 19,541 |
Income taxes payable |
| 125 |
|
| 100 |
Loan payable |
| 56,910 |
|
| 56,486 |
Senior secured notes payable |
| 630,000 |
|
| 160,000 |
Revolving line of credit |
| 229,980 |
|
| 229,980 |
Unsecured notes payable, net of discount of $45,269 at March 31, 2015 |
| 374,731 |
|
| 20,000 |
Total current liabilities |
| 1,721,784 |
|
| 840,053 |
LONG-TERM LIABILITIES: |
|
|
|
|
|
Loan payable |
| 119,446 |
|
| 133,834 |
Unsecured notes payable, net of discount of $59,768 at December 31, 2014 |
| - |
|
| 360,232 |
Total long-term liabilities |
| 119,446 |
|
| 494,066 |
TOTAL LIABILITIES |
| 1,841,230 |
|
| 1,334,119 |
COMMITMENTS AND CONTINGENCIES (NOTE 9) |
|
|
|
|
|
STOCKHOLDERS EQUITY: |
|
|
|
|
|
|
|
|
|
|
|
Series D preferred stock, $0.0001 par value, 178,924 shares issued and outstanding at March 31, 2015 and December 31, 2014; liquidation preference of $789,300 at March 31, 2015 and $810,216 at December 31, 2014 |
| 18 |
|
| 18 |
|
|
|
|
|
|
Common stock, $0.0001 par value, 20,000,000 shares authorized; 11,061,114 issued and 11,017,641 outstanding at March 31, 2015 and 9,495,045 issued and 10,952,356 outstanding at December 31, 2014 |
| 1,102 |
|
| 1,095 |
Additional paid-in capital |
| 14,260,989 |
|
| 14,111,944 |
Accumulated deficit during development stage |
| (13,560,319) |
|
| (12,905,124) |
Total stockholders equity |
| 701,790 |
|
| 1,207,933 |
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY | $ | 2,543,020 |
| $ | 2,542,052 |
The accompanying notes are an integral part of these consolidated financial statements.
3
HEATWURX, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
| Three Months Ended March 31, | ||||
| 2015 |
| 2014 | ||
REVENUE: |
|
|
| ||
Equipment sales | $ | 32,760 |
| $ | 7,445 |
Service revenue |
| 8,830 |
|
| 12,900 |
Other revenue |
| 5,000 |
|
| - |
Total revenues |
| 46,590 |
|
| 20,435 |
|
|
|
|
|
|
COST OF GOODS SOLD |
| 29,269 |
|
| 9,140 |
GROSS PROFIT |
| 17,321 |
|
| 11,205 |
|
|
|
|
|
|
EXPENSES: |
|
|
|
|
|
Selling, general and administrative |
| 601,893 |
|
| 805,004 |
Research and development |
| 14,450 |
|
| 99,769 |
Impairment on goodwill |
| - |
|
| 390,659 |
Total expenses |
| 616,343 |
|
| 1,295,432 |
|
|
|
|
|
|
LOSS FROM OPERATIONS |
| (599,022) |
|
| (1,284,227) |
|
|
|
|
|
|
OTHER INCOME AND EXPENSE: |
|
|
|
|
|
Interest income |
| 1,252 |
|
| 72 |
Interest expense |
| (46,811) |
|
| (60,096) |
Total other income and expense |
| (45,559) |
|
| (60,024) |
|
|
|
|
|
|
LOSS BEFORE INCOME TAXES |
| (644,581) |
|
| (1,344,251) |
Income taxes |
| (25) |
|
| (25) |
NET LOSS | $ | (644,606) |
| $ | (1,344,276) |
|
|
|
|
|
|
Preferred Stock Cumulative Dividend |
| 10,589 |
|
| 38,548 |
Net loss applicable to common stockholders | $ | (655,195) |
| $ | (1,382,824) |
Net loss per common share basic and diluted | $ | (0.06) |
| $ | (0.17) |
Weighted average shares outstanding used in calculating net loss per common share |
| 10,997,056 |
|
| 8,264,992 |
The accompanying notes are an integral part of these consolidated financial statements.
4
HEATWURX, INC.
CONSOLIDATED STATEMENT OF CASH FLOWS
| Three Months Ended March 31, | ||||
| 2015 |
| 2014 | ||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
| ||
Net loss | $ | (644,606) |
| $ | (1,344,276) |
Adjustments to reconcile net loss to cash flows used in operating activities: |
|
|
|
|
|
Depreciation expense |
| 29,089 |
|
| 21,775 |
Amortization of intangible assets |
| 89,285 |
|
| 89,285 |
Amortization of discount on note payable |
| 14,499 |
|
| 21,086 |
Impairment of goodwill |
| - |
|
| 390,659 |
Non-cash expenses exchanged for services |
| 25,500 |
|
| - |
Stock-based compensation |
| 35,552 |
|
| 129,408 |
Changes in current assets and liabilities: |
|
|
|
|
|
Increase in receivables |
| (87,269) |
|
| (1,145) |
Decrease (increase) in prepaid and other current assets |
| 89,434 |
|
| (7,056) |
Decrease (increase) in inventory |
| 24,889 |
|
| (119,236) |
Increase in consigned inventory |
| (124,448) |
|
| - |
Increase in income taxes payable |
| 25 |
|
| 25 |
Decrease in accounts payable |
| (12,516) |
|
| (23,080) |
Decrease in accrued liabilities |
| (35,363) |
|
| (143,996) |
Increase in deferred revenue |
| 84,964 |
|
| - |
Increase (decrease) in interest payable |
| 8,877 |
|
| (1,187) |
Cash used in operating activities |
| (502,088) |
|
| (987,738) |
CASH FLOWS FROM INVESTING ACTIVITES: |
|
|
|
|
|
Purchases of property and equipment |
| (1,399) |
|
| (13,772) |
Acquisition of business |
| - |
|
| 3,355 |
Cash used in investing activities |
| (1,399) |
|
| (10,417) |
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|
Proceeds from issuance of unsecured notes payable |
| - |
|
| 1,000,000 |
Proceeds from issuance of senior secured notes payable |
| 450,000 |
|
| - |
Repayment of senior subordinated note payable |
| - |
|
| (250,000) |
Proceeds from issuance of common shares |
| 88,000 |
|
| - |
Proceeds from issuance of Series D preferred shares |
| - |
|
| 153,996 |
Repayment on equipment loan payable |
| (13,964) |
|
| (10,457) |
Cash provided by financing activities | $ | 524,036 |
| $ | 893,539 |
|
|
|
|
|
|
NET CHANGE IN CASH AND CASH EQUIVALENTS |
| 20,549 |
|
| (104,616) |
CASH AND CASH EQUIVALENTS, beginning of period |
| 21,234 |
|
| 186,864 |
CASH AND CASH EQUIVALENTS, end of period | $ | 41,783 |
| $ | 82,248 |
The accompanying notes are an integral part of these financial statements.
5
HEATWURX, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. PRINCIPAL BUSINESS ACTIVITIES:
Organization and Business - Heatwurx, Inc. (Heatwurx, the Company) is an asphalt repair equipment and technology company. Heatwurx was incorporated on March 29, 2011 as Heatwurxaq, Inc. and subsequently changed its name to Heatwurx, Inc. on April 15, 2011. On January 1, 2014, Heatwurx acquired Dr. Pave, LLC, a service company offering asphalt repair and restoration. On July 22, 2014 Dr. Pave Worldwide, LLC was organized to offer franchises for the operation of businesses that use the Heatwurx branded equipment and Heatwurx repair process to repair, maintain and preserve roadways. (Note 5)
2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:
Basis of Presentation - These unaudited interim consolidated financial statements and related notes are presented in accordance with the accounting principles generally accepted in the United States (U.S. GAAP) and are expressed in U.S. dollars. Accordingly, they do not include all disclosures required in the annual financial statements by U.S. GAAP. In the opinion of management, the accompanying unaudited interim financial statements contain all adjustments considered necessary to present fairly in all material respects the financial position as of March 31, 2015.
These financial statements should be read in conjunction with the audited financial statements and accompanying notes for the year ended December 31, 2014, and have been prepared on a consistent basis with the accounting policies described in Note 2 - Summary of Significant Accounting Policies of the Notes to Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2014. Our accounting policies did not change in the first three months of 2015. Operating results for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015 or any future period.
The Companys consolidated financial statements include Dr. Pave, LLC and Dr. Pave Worldwide, LLC; both wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in the consolidated financial statements.
The Companys financial statements are prepared using U.S. GAAP applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business.
The Company also faces certain risks and uncertainties which are present in many emerging companies regarding product development, future profitability, ability to obtain future capital, protection of patents and property rights, competition, rapid technological change, government regulations, recruiting and retaining key personnel, and third party manufacturing organizations.
To date we have relied exclusively on private placements with a small group of investors to finance our business and operations. We have had little revenue since our inception. For the three months ended March 31, 2015, the Company incurred a net loss of approximately $645,000 and utilized approximately $502,000 in cash flows from operating activities. The Company had cash on hand of approximately $42,000 as of March 31, 2015. Successful completion of the Companys marketing program and its transition to profitable operations is dependent upon obtaining additional financing adequate to fulfill its commercialization activities, and achieve a level of revenues adequate to support the Companys cost structure. Many of the Companys objectives to establish profitable business operations rely upon the occurrence of events outside its control; there is no assurance that the Company will be successful in accomplishing these objectives. The Company cannot assure that additional debt, equity or other funding will be available to it on acceptable terms, if at all. If the Company fails to obtain additional funding when needed, it would be forced to scale back, or terminate its operations, or seek to merge with or be acquired by another company.
6
Management anticipates that the Company will require significant additional funds to continue operations. As of March 31, 2015, we had approximately $42,000 cash on hand and were spending approximately $220,000 per month, of which only a minor amount was satisfied by gross proceeds from operations. Hence, the amount of cash on hand is not adequate to meet our operating expenses over the next twelve months. As of May 14, 2015, the Company received cash in aggregate of $629,000 and converted a $20,000 unsecured note into the $2,000,000 senior secured debt offering issued in February. Based upon the Companys current financial position, the Company does not believe it will be able to satisfy the mandatory principal payments in 2015 under the $2,000,000 senior secured debt. The Company will work with the lenders to explore extension or conversion options. These notes are secured by all of the assets of the Company, including intellectual property rights. If the Company defaults on the loan payments the Companys assets may be foreclosed upon.
The issues described above raise substantial doubt about the Companys ability to continue as a going concern. Although the Company has commenced a new $2,000,000 secured debt offering, it cannot guarantee it will be able to raise the entire offering amount, if any. The Company is solely reliant on raising additional debt and capital in order to maintain its current operations. To date the Company, has been able to raise debt and equity financing through the assistance of a small number of our investors who have been substantial participants in its debt and equity offerings since the Companys formation. If these investors choose not to assist the Company with its capital raising initiatives in the future, the Company does not expect that it would be able to obtain any alternative forms of financing at this time and the Company would not be able to continue to satisfy its current or long term obligations. Based upon the Companys current monthly spend the Company anticipates the need to raise at least $2,600,000 to meet its cash flow requirements for the next twelve months. If the Company successfully raises $2,000,000 in the private debt offering, the proceeds the Company will receive and anticipated revenues from equipment sales and service performed may not be sufficient to fund the Companys operations, including the Companys expected capital expenditures, through the next twelve months. Without additional funds, the Company will be required to reduce operations, curtail any future growth opportunities, cease operations all together, or seek to merge with or be acquired by another company.
The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be different should the Company be unable to continue as a going concern.
Revenue Recognition - The Company sells its equipment (HWX-30 heater, HWX-30S mobile heater and HWX-AP-40 asphalt processor), as well as certain consumables to third parties. Equipment sales revenue is recognized when all of the following criteria are satisfied: (a) persuasive evidence of a sales arrangement exists; (b) price is fixed and determinable; (c) collectability is reasonably assured; and (d) delivery has occurred. Persuasive evidence of an arrangement and a fixed or determinable price exist once the Company receives an order or contract from a customer. The Company assesses collectability at the time of the sale and if collectability is not reasonably assured, the sale is deferred and not recognized until collectability is probable or payment is received. Typically, title and risk of ownership transfer when the equipment is shipped.
Other revenue represents license fees and franchise fees.
Recent Accounting Pronouncements - From time to time, the Financial Accounting Standards Board (FASB) or other standard setting bodies issue new accounting pronouncements. Updates to the FASB Accounting Standards Codification are communicated through issuance of an Accounting Standards Update (ASU). Unless otherwise discussed, we believe that the impact of recently issued guidance, whether adopted or to be adopted in the future, is not expected to be material to our financial statements upon adoption.
7
The Financial Accounting Standards Board recently issued Accounting Standards Update (ASU) 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entitys Ability to Continue as a Going Concern. The amendments require management to assess an entitys ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of managements plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of managements plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter.
The Financial Accounting Standards Board recently issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), was issued in three parts: (a) "Summary and Amendments That Create Revenue from Contracts with Customers (Topic 606) and Other Assets and Deferred CostsContracts with Customers (Subtopic 340-40)," (b) "Conforming Amendments to Other Topics and Subtopics in the Codification and Status Tables," and (c) "Background Information and Basis for Conclusions." The new presentation guidance is effective for interim and annual periods beginning after December 15, 2016. The Company is considering the impact of the adoption of ASU 2014-09 on its results of operations, financial condition and cash flows.
3. NOTE RECEIVABLE:
The Company entered into an Equipment Purchase and License Agreement, in which the Company financed $89,964 with a note bearing 12% interest per annum payable monthly. Interest only payments are due monthly with principal and unpaid interest due on February 28, 2016. The Company has the option to extend the financing for an additional twelve months, if the licensee is in good standing. Interest of $1,250 is accrued as of March 31, 2015. Revenues under this agreement are recorded in deferred revenue and will be recognized in accordance with the Companys revenue recognition policy.
4. PROPERTY AND EQUIPMENT:
A summary of the cost of property and equipment, by component, and the related accumulated depreciation is as follows:
|
| March 31, 2015 |
| December 31, 2014 | ||
Computer equipment & software |
| $ | 31,551 |
| $ | 30,152 |
Demo equipment |
|
| 599,432 |
|
| 599,432 |
Leasehold improvements |
|
| 22,580 |
|
| 22,580 |
|
|
| 653,563 |
|
| 652,164 |
Accumulated depreciation |
|
| (214,840) |
|
| (185,751) |
|
| $ | 438,723 |
| $ | 466,413 |
Depreciation expense was $29,089 and $21,775 for the three months ended March 31, 2015 and 2014, respectively.
5. ASSET PURCHASE AGREEMENT:
On April 15, 2011, the Company entered into an Asset Purchase Agreement with an individual who is a founder and a current stockholder. Pursuant to the agreement, the Company purchased the related business and activities of the design, manufacture and distribution of asphalt repair machinery under the Heatwurx brand. The total purchase price was $2,500,000.
8
The business essentially consisted of the investment in research and development of the technology, the patents applied for as a result of the research and development activities and certain distribution relationships that were in process, but not finalized as of the acquisition date. Collectively, these investments constitute the in-process research and development the Company refers to as the asphalt preservation and repair solution. The Company capitalized $2,500,000 of in-process research and development related to this asphalt preservation and repair solution. As of October 1, 2012, in-process research and development is now classified as developed technology and amortized over its estimated useful life of seven years. The initial estimated fair value of the in-process research and development was determined using the income approach. Under the income approach, the expected future cash flows from the asset are estimated and discounted to its net present value at an appropriate risk-adjusted rate of return. As of March 31, 2015, the Companys developed technology intangible asset had a value of $1,607,145, net of accumulated amortization of $892,855. Amortization expense for the three months ended March 31, 2015 and 2014 was $89,285.
In conjunction with the Asset Purchase Agreement, the Company granted 200,000 performance stock options to a founder of the Company with an exercise price of $0.40 per share and a term of seven years. Following the effectiveness of the seven for one stock split that was completed in October 2011, the 200,000 performance stock options were exchanged for 1,400,000 performance stock options with an exercise price of $0.057 per share. On February 10, 2015, the founder of the Company elected to cancel the 1,400,000 performance stock options.
6. NOTES PAYABLE:
Unsecured Notes Payable - On December 11, 2014, the Company received $20,000 in short-term unsecured debt. The note bears interest at 12% per annum payable monthly, with principal and unpaid interest due and payable on February 15, 2015. As of December 31, 2014; principal in the amount of $20,000 was outstanding. On February 23, 2015, the note was converted into a senior secured note payable under a $2 million loan agreement with JMW Fund, Richland Fund, and San Gabriel Fund.
On January 6, 2014, the Company commenced a non-public offering of notes and warrants of up to $1,000,000. The promissory notes will bear interest at 12% per annum payable monthly, with principal and unpaid interest due and payable on January 6, 2016. As additional consideration for a lender to enter into the Loan Agreement, the Company has agreed to issue to each lender one common stock purchase warrant for each $3.00 loaned to the Company. The Warrants expire three years following the date of issuance and may not be offered for sale, sold, transferred or assigned without the consent of the Company. The three-year warrants will be exercisable immediately at $3.00 per share.
As of March 31, 2015, the Company has total notes outstanding in the aggregate principal amount of $350,000 and were issued with an aggregate of 116,665 warrants to the investors. The warrants are detachable and exercisable immediately. The Company allocated the fair value of the warrants in the amount of $102,357 as a discount on notes payable which is amortized over the term of the notes to interest expense in the income statement. The Company recognized amortization of discount on notes payable in interest expense of $12,664 and $20,348 during the first quarter of 2015 and 2014, respectively. As of March 31, 2015 there were notes outstanding with a carrying amount of $310,459, net of $39,541 debt discount.
On March 1, 2014, the Company commenced a similar non-public offering of notes and warrants up to $3,000,000 which closed December 31, 2014. The promissory notes bear interest at 12% per annum payable monthly, with principal and unpaid interest due and payable on January 6, 2016. Each lender in the offering received one warrant for each $3.00 loaned. The three-year warrants will be exercisable immediately at $3.00 per share. As of March 31, 2015, the Company has total notes outstanding in the aggregate principal amount of $70,000 and were issued with an aggregate of 23,332 warrants to the investors. The warrants are detachable and exercisable immediately. The Company allocated the fair value of the warrants in the amount of $12,801 as a discount on notes payable which is amortized over the term of the notes to interest expense in the income statement. The Company recognized amortization of discount on notes payable in interest expense of $1,855 during the first quarter of 2015. As of March 31, 2015 there were notes outstanding with a carrying amount of $64,272, net of $5,728 debt discount.
Interest on the unsecured notes payable totaling $4,280 was outstanding at March 31, 2015.
9
Revolving line of credit - The Company assumed a revolving line of credit through the acquisition of Dr. Pave in the amount of $229,980. The balance on the line of credit bears interest at a rate of 12% per annum. Interest is payable monthly on the first day of each month. The outstanding principal balance as of July 1, 2015 shall become due and payable in sixty (60) equally amortized monthly installments of principal and interest due on the fifteenth day of each calendar month until paid in full. Notwithstanding anything to the contrary herein, all outstanding debt shall be due and payable in full on or before December 31, 2015.
Interest on the revolving line of credit totaling $9,150 was outstanding at March 31, 2015.
Secured Notes Payable - The Company assumed secured notes payable through the acquisition of Dr. Pave in the amount of $160,000. The notes bear interest at a rate of 12% per annum. Interest is payable monthly on the first day of each month. The principal amount and all then accrued and unpaid interest is payable on June 30, 2015.
On February 16, 2015, the Company entered into a Senior secured loan agreement with JMW Fund, Richland Fund, and San Gabriel Fund (collectively, the lenders) whereby the lenders agreed to loan to the Company up to an aggregate of $2,000,000. The interest rate on the notes is 12% per annum and monthly interest payments are due the first day each month beginning March 1, 2015. The notes mature six months from the date of issuance. If any interest payment remains unpaid in excess of 90 days, and the lender has not declared the entire principal and unpaid accrued interest due and payable, the interest rate on that amount only will be increased to 18% per annum, until the past due interest amount is paid in full. The notes and any future notes under the loan agreement are secured by all of the assets of the Company, including intellectual property rights. As of March 31, 2015 there were notes outstanding with an aggregate principal amount of $470,000.
Interest on the secured notes payable totaling $14,988 was outstanding at March 31, 2015.
Loan Payable
In September 2012, the Company financed the purchase of equipment used for transportation and service work performed. The note, in the original amount of $142,290, bears interest at a rate of 2.6% per annum and matures on September 4, 2017.
In August 2013, the Company financed the purchase of a truck to transport our equipment used in service and demonstrations. The loan, in the amount of $83,507, bears interest at a rate of 6.1% per annum and matures on December 1, 2018.
In September 2014, the Company financed the purchase of equipment used in connection with the Heatwurx equipment to facilitate demonstrations and repairs. The loan, in the amount of $49,204; matures on October 15, 2018.
As of March 31, 2015, the loans are subject to mandatory principal payments as follows:
Year | Payments | |
2015 | $ | 902,502 |
2016 |
| 478,214 |
2017 |
| 49,856 |
2018 |
| 25,764 |
2019 |
| -- |
Total principal payments | $ | 1,456,336 |
Based upon the Companys current financial position, the Company does not believe it will be able to satisfy the mandatory principal payments in 2015. The Company will work with the lenders to explore extension or conversion options. There is no guarantee the lenders will accommodate our requests. As of May 14, 2015; $649,000 is outstanding and payable in 2015 under the Secured Notes. These notes are secured by all of the assets of the Company, including intellectual property rights. If the Company defaults on the loan payments the Companys assets may be foreclosed upon.
10
7. STOCKHOLDERS EQUITY:
Common Stock - The Company has authorized 20,000,000 common shares with a $0.0001 par value. There were 11,061,114 shares issued and 11,017,641 outstanding at March 31, 2015 and 9,495,045 shares issued and 10,952,356 outstanding at December 31, 2014.
On October 1, 2014, the Company commenced a non-public equity offering of units at $1.75 per unit (the Units). Each Unit consists of one common share and one-half warrant, with each whole warrant exercisable at $2.00 per share. The purchase price for the Units is payable in either cash, conversion of outstanding Series D preferred shares or certain outstanding promissory notes. During the three months ended March 31, 2015 the Company issued 50,285 shares of common stock and warrants to purchase 25,141 shares of common stock for cash proceeds of $88,000.
On March 13, 2015 the Company issued 15,000 common shares in exchange for consulting services.
Preferred Stock - The Company has authorized 4,500,000 shares of Preferred Stock with a $0.0001 par value. As holders of any series of preferred stock convert into common shares the preferred shares are no longer outstanding and become available for reissuance. As of March 31, 2015 and December 31, 2014, there were 178,924 preferred shares outstanding.
Series D Preferred Stock - As of March 31, 2015 and December 31, 2014 there were 178,924 shares of Series D preferred stock outstanding.
As of March 31, 2015, the Company has 178,924 Series D preferred stock outstanding. Holders of Series D preferred stock accrue dividends at the rate per annum of $0.24 per share, payable on a quarterly basis. As dividends are accrued and payable quarterly on the Series D preferred stock, the Company paid dividends of $31,475 and $44,018 during the three months ended March 31, 2015 and 2014, respectively. As of March 31, 2015 the Company has dividends payable in accrued expenses of $15,819.
The holders of the Series D preferred stock have conversion rights equivalent to such number of fully paid and non-assessable shares of common stock as is determined by dividing the Series D original issue price of $3.00 by the then applicable conversion price. Each Series D Share will convert into one share of our common stock at any time at the option of the holder of the Series D Shares or will be converted at the option of the Company at any time the trading price of our common stock is at least $4.50 per share for ten consecutive trading days. The conversion ratio is subject to anti-dilution adjustments, including in the event that the Company issues equity securities at a price equivalent to or less than the conversion price in effect immediately prior to such issue.
The holders of Series D preferred stock have a liquidation preference over the holders of the Companys common stock equivalent to the purchase price per share of the Series D preferred stock plus any accrued and unpaid dividends, whether or not declared, on the Series D preferred stock. A liquidation would be deemed to occur upon the happening of customary events, including transfer of all or substantially all of the Companys common stock or assets or a merger, or consolidation. The Company believes that such liquidation events are within its control and therefore the Company has classified the Series D preferred stock in stockholders equity.
The holders of Series D preferred stock vote together as a single class with the holders of the Companys common stock on all action to be taken by the Companys stockholders. Each share of Series D preferred stock entitles the holder to the number of votes equal to the number of shares of common stock into which the shares of the Series D preferred stock are convertible as of the record date for determining stockholders entitled to vote on such matter.
The Company agreed to use its best efforts to register the shares underlying the warrants issued in the Series D preferred stock offering and the Private equity offering dated October 1, 2014.
11
Stock Options
| Number of Options | Weighted Average Exercise Price | Weighted Average Remaining Life (Years) |
Balance, December 31, 2013 | 1,320,000 | $ 2.23 | 3.44 |
Granted | 298,000 | $ 3.00 |
|
Exercised | -- | -- |
|
Cancelled | (371,500) | $ 2.46 |
|
Balance, December 31, 2014 | 1,246,500 | $ 2.35 | 2.83 |
Granted | -- | -- |
|
Exercised | -- | -- |
|
Cancelled | (10,000) | $ 3.00 |
|
Balance, March 31, 2015 | 1,236,500 | $ 2.34 | 2.10 |
Exercisable, December 31, 2014 | 882,583 | $ 2.20 |
|
Exercisable, March 31, 2015 | 900,083 | $ 2.21 |
|
The fair value of each stock option granted was estimated on the date of grant using the Black Scholes option pricing model with the following assumptions:
| March 31, 2015 |
Risk-free interest rate range | 1.49%-1.71% |
Expected life | 5.0 Years |
Vesting period | 0 - Years |
Expected volatility | 42% |
Expected dividend | - |
Fair value range of options at grant date | $0.671 - $1.167 |
The Company recorded stock-based compensation expense of $35,552 and $129,408 during the three months ended March 31, 2015 and 2014, respectively.
As of March 31, 2015 there was $272,490 of unrecognized compensation expense related to the issuance of the stock options.
Performance Stock Options
There were no performance stock options granted during the three months ended March 31, 2015.
| Number of Options |
| Weighted Average Exercise Price |
Balance, December 31, 2013 | 1,440,000 |
| $ 0.11 |
Granted | -- |
| -- |
Exercised | -- |
| -- |
Cancelled | -- |
| -- |
Balance, December 31, 2014 | 1,440,000 |
| $ 0.11 |
Granted | -- |
| -- |
Exercised | -- |
| -- |
Cancelled | (1,400,000) |
| $ 0.06 |
Balance, March 31, 2015 | 40,000 |
| $ 2.00 |
Exercisable, December 31, 2014 and March 31, 2015 | 40,000 |
| $ 2.00 |
See Note 5 for further discussion of the performance options.
12
Warrants
The Company issued 25,141 warrants in connection with the private equity offering dated October 1, 2014 discussed above. Each unit consisted of one share of Common stock and one-half warrant, with each whole warrant exercisable at $2.00 per share and grants the right to purchase a share of the Companys common stock. The warrants expire three years from the date of issuance and are exercisable immediately.
| Number of Warrants | Weighted Average Exercise Price | Weighted Average Remaining Life (Years) |
Balance, December 31, 2013 | 363,824 | $ 3.00 | 1.88 |
Granted | 2,061,156 | $ 2.39 |
|
Exercised | -- | -- |
|
Cancelled | -- | -- |
|
Balance, December 31, 2014 | 2,424,980 | $ 2.48 | 2.28 |
Granted | 25,141 | $2.00 |
|
Exercised | -- | -- |
|
Cancelled | -- | -- |
|
Balance, March 31, 2015 | 2,450,121 | $2.48 | 2.04 |
8. NET LOSS PER COMMON SHARE:
The Company computes loss per share of common stock using the two-class method required for participating securities. The Companys participating securities include all series of its convertible preferred stock. Undistributed earnings allocated to these participating securities are added to net loss in determining net loss applicable to common stockholders. Basic and Diluted loss per share are computed by dividing net loss applicable to common stockholder by the weighted-average number of shares of common stock outstanding.
Outstanding options and warrants underlying 3,686,621 shares were not included in the computation of diluted loss per share because the exercise price was greater than the average market price of the common shares and, therefore, the effect would be anti-dilutive.
The calculation of the numerator and denominator for basic and diluted net loss per common share is as follows:
| For the three months ended March 31, | ||||
| 2015 |
| 2014 | ||
Net Loss | $ | (644,606) |
| $ | (1,344,276) |
Basic and diluted: |
|
|
|
|
|
Preferred stock cumulative dividend - Series B (1) |
| -- |
|
| (22,368) |
Preferred stock cumulative dividend - Series C |
| -- |
|
| 1,904 |
Preferred stock cumulative dividend - Series D |
| 10,589 |
|
| 59,012 |
Income applicable to preferred stockholders |
| 10,589 |
|
| 38,548 |
Net loss applicable to common stockholders | $ | (655,195) |
| $ | (1,382,824) |
(1)
Upon conversion of the Series B preferred stock into common stock, the holders of the Series B preferred stock were no longer entitled to the dividends recorded in the adjustment to net loss applicable to common shareholders in prior periods. As a result, current year reported dividends were adjusted downward to reflect this release of accumulated dividends.
13
9. COMMITMENTS AND CONTINGENCIES:
Lease Commitments - The Company leases warehouse and office space for the equipment and operations located in Gardena, CA. The lease term continues through July 2015.
Total rent expense for the three months ended March 31, 2015 and 2014 was $15,057 and $19,099, respectively.
The Companys remaining commitment under its current lease term for 2015 is approximately $10,000.
10. RELATED PARTY TRANSACTIONS:
Consulting arrangements
The Company has a consulting arrangement with Heather Kearns, the Interim Chief Financial officer and paid consulting fees of $27,000 during the three months ended March 31, 2015.
Dividend and Interest activity
As of March 31, 2015 the Company has secured notes payable with Mr. Yorke, as the manager of, JMW Fund, LLC, The Richland Fund, LLC and The San Gabriel Fund, LLC in the aggregate amount of $630,000; an outstanding balance of $138,000 on the revolving line of credit. Mr. Yorke, as the manager, received or has accrued interest payments from loans payable in the three months ended 2015 totaling $15,692. See Note 12 for additional disclosure.
During the three months ended March 31, 2015, Mr. Gus Blass III, a member of our board of directors and a stockholder, received or has accrued dividends from preferred stock totaling $5,918. In addition, Mr. Gus Blass II, a former member of our board of directors and father to Mr. Gus Blass III, a member of our board of directors, was issued an unsecured note payable in the amount of $250,000 during 2014, paying interest at 12% per annum, with a maturity date of January 6, 2016. Mr. Blass II, received or has accrued interest payments in 2015 totaling $7,397.
Reginald Greenslade, a member of our board of directors and a stockholder, has an outstanding balance of $45,980 on the revolving line of credit to Mr. Greenslade. Mr. Greenslade received or has accrued interest in three months ended March 31, 2015 totaling $1,361.
During the three months ended March 31, 2015, David Dworsky, a member of our board of directors and former Chief Executive Officer, received or has accrued dividends from preferred stock totaling $89.
11. SUPPLEMENTAL CASH FLOW INFORMATION
| Three Months ended March 31, | ||||
| 2015 |
| 2014 | ||
Cash paid for interest | $ | 12,557 |
| $ | 39,116 |
Series C Dividend payable in accrued expenses | $ | -- |
| $ | 17,574 |
Series D Dividend payable in accrued expenses | $ | 15,819 |
| $ | 45,665 |
|
|
|
|
|
|
Non-Cash investing and financing transactions |
|
|
|
|
|
Shares issued for consulting services | $ | 25,500 |
| $ | -- |
Beneficial conversion feature on warrants issued in conjunction with Series D preferred shares | $ | -- |
| $ | 13,347 |
Shares issued in acquisition of Dr. Pave | $ | -- |
| $ | 175,000 |
14
12. SUBSEQUENT EVENTS
On April 30, 2015, David Dworsky, resigned from his position as Chief Executive Officer but will remain a member of the Companys board of directors. In connection with Mr. Dworskys willingness to continue to serve as a director of the Company, the Board of Directors (with Mr. Dworsky abstaining) approved the grant of options to purchase 125,000 shares of the Companys common stock. The options are exercisable at $1.50 per share and vested on the grant date.
Mr. Dworsky also agreed to cancel outstanding options to purchase 300,000 shares of the Companys common stock.
Heather Kearns, the Interim Chief Financial Officer will also act as the Interim Chief Executive Officer while the Company and Board of Directors conducts a search for the best candidate as President and Chief Executive Officer. In connection with Ms. Kearns acceptance of Interim Chief Executive Officer, the Board of Directors approved the grant to her of options to purchase 125,000 shares of the Companys common stock. The options are exercisable at $1.50 per share with 50% vesting on the grant date and the remaining 50% vesting one year from the grant date.
On April 30, 2015, Glenn Russell accepted his appointment as a director of the Company replacing Stephen Garland who resigned on March 17, 2015.
Debt offerings
The Company entered into notes under the senior secured loan agreement with JMW Fund, Richland Fund, and San Gabriel Fund in an aggregate principal amount of $179,000, subsequent to the quarter-end. The interest rate on the notes is 12% per annum and monthly interest payments are due the first day each month. The notes mature six months from the date of issuance. If any interest payment remains unpaid in excess of 90 days, and the lender has not declared the entire principal and unpaid accrued interest due and payable, the interest rate on that amount only will be increased to 18% per annum, until the past due interest amount is paid in full. The notes and any future notes under the loan agreement are secured by all of the assets of the Company, including intellectual property rights. Upon the occurrence of an event of default the lenders have the right to foreclose on the assets of the Company.
15
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis should be read in conjunction with the Managements Discussion and Analysis of Financial Condition and Results of Operations section and audited consolidated financial statements and related notes thereto included in our 2014 Annual Report on Form 10-K, and with the unaudited condensed consolidated financial statements and related notes thereto presented in this Quarterly Report on Form 10-Q.
Forward-Looking Statements
The statements contained in this report that are not historical facts are forward-looking statements that represent managements beliefs and assumptions based on currently available information. Forward-looking statements include the information concerning our possible or assumed future results of operations, business strategies, need for financing, competitive position, potential growth opportunities, potential operating performance improvements, ability to retain and recruit personnel, the effects of competition and the effects of future legislation or regulations. Forward-looking statements include all statements that are not historical facts and can be identified by the use of forward-looking terminology such as the words believes, intends, may, should, anticipates, expects, could, plans, or comparable terminology or by discussions of strategy or trends. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we cannot give any assurances that these expectations will prove to be correct. Such statements by their nature involve risks and uncertainties that could significantly affect expected results, and actual future results could differ materially from those described in such forward-looking statements.
Factors that may cause actual results to differ materially from current expectations include, but are not limited to:
·
risks associated with the asphalt repair industry, including competition, increases in wages, labor relations, energy and fuel costs, actual and threatened pandemics, actual and threatened terrorist attacks, and downturns in domestic and international economic and market conditions;
·
risks associated with the asphalt repair industry, including changes in laws or regulations, increases in taxes, rising insurance premiums, costs of compliance with environmental laws and other governmental regulations;
·
the availability and terms of financing and capital and the general volatility of securities markets;
·
changes in the competitive environment in the asphalt repair industry;
·
risks related to natural disasters;
·
litigation; and
·
other risk factors discussed in the 2014 Annual Report on Form 10-K, filed by the Company with the Securities and Exchange Commission.
Should one or more of these risks materialize (or the consequences of such a development worsen), or should the underlying assumptions prove incorrect, actual results could differ materially from those expected. We disclaim any intention or obligation to update publicly or revise such statements whether as a result of new information, future events or otherwise.
Overview and Basis of Presentation
Heatwurx, Inc. was incorporated under the laws of the State of Delaware on March 29, 2011 as Heatwurxaq, Inc. and subsequently changed its name to Heatwurx, Inc. on April 15, 2011.
We are an asphalt preservation and repair, equipment company. Our innovative, and eco-friendly hot-in-place recycling process corrects surface distresses within the top 3 inches of existing pavement by heating the surface material to a temperature between 325° and 375° Fahrenheit with our electrically powered infrared heating equipment, mechanically loosening the heated material with our processor/tiller attachment that is optimized for producing a seamless repair, and mixing in additional recycled asphalt pavement and a binder (asphalt-cement), and then compacting repaired area with a vibrating roller or compactor. We consider our equipment to be eco-friendly as the Heatwurx process reuses and rejuvenates distressed asphalt, uses recycled asphalt pavement for filler material, eliminates travel to and from asphalt batch plants, and extends the life of the roadway. We believe our equipment, technology and processes provide savings over other processes that can be more labor and equipment intensive.
16
Our hot-in-place recycling process and equipment was selected by the Technology Implementation Group of the American Association of State Highway Transportation Officials (AASHTO TIG) as an additionally Selected Technology for the year 2012. We develop, manufacture and intend to sell our unique and innovative and eco-friendly equipment to federal, state and local agencies as well as contractors for the repair and rehabilitation of damaged and deteriorated asphalt surfaces.
In January 2014, we acquired Dr. Pave, LLC a service company offering asphalt repair and restoration utilizing the Heatwurx asphalt repair technology. Our company, together with Dr. Pave, offers asphalt restoration services to municipalities and the commercial sector in southern California.
Effective July 22, 2014, we established a new entity named Dr. Pave Worldwide LLC to house our franchise program providing franchisees with the exclusive Heatwurx equipment and processing. We formally launched our franchise sales program throughout the U.S. in the third quarter of 2014; however, to date, no franchises have been sold.
Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. However, we are choosing to opt out of such extended transition period, and as a result, we will comply with new or revised standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. Section 107 of the JOBS Act provides that our decision to opt out of the extended transition period for complying with new or revised accounting standards is irrevocable.
Results of operations
The following discussion of the financial condition and results of operations should be read in conjunction with the financial statements included herewith. This discussion should not be construed to imply that results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future.
For the three months ended March 31, 2015 compared to the three months ended March 31, 2014
For the three months ended March 31, 2015, our net loss was $644,606, compared to a net loss of $1,344,276 for the same period of 2014. Further description of these losses is provided below.
Revenue
Revenue increased to approximately $47,000 for the three months ended March 31, 2015 from approximately $20,000 for the three months ended March 31, 2014, as a result of increased equipment sales offset by a decrease in service revenue during the period.
Cost of goods sold
Cost of goods sold increased to approximately $29,000 for the three months ended March 31, 2015 from approximately $9,000 for the three months ended March 31, 2014.
Selling, general and administrative
Selling, general and administrative expenses decreased to approximately $602,000 for the three months ended March 31, 2015 from approximately $805,000 for the three months ended March 31, 2014. The decrease in selling, general and administrative expenses is principally due to a decrease in employee expenses of approximately $152,000; and a decrease in advertising and promotion of approximately $70,000; offset by an increase in office expenses of approximately $9,000 which includes commercial insurance, rent and other expenses, and an increase in legal fees of approximately $10,000.
17
As part of the acquisition of Dr. Pave in 2014, the Company recognized goodwill in the amount of $390,659 as part of the total consideration paid. The Company determined goodwill should be immediately impaired as of the acquisition date based on the lack of service revenue for the prior year. An impairment of goodwill from the acquisition in the amount of $390,659, was recorded as an operating expense in the income statement, during the three months ended March 31, 2014.
Research and Development
Research and development decreased to approximately $14,000 for the three months ended March 31, 2015 from approximately $100,000 for the three months ended March 31, 2014, as a result of fewer patent applications being filed thereby reducing the legal fees associated therewith, a decrease in manufacturing research and development costs, and a decrease in consulting fees.
Liquidity and capital resources
Overview
To date we have relied exclusively on private placements with a small group of investors and loans from a small group of related parties to finance our business and operations. We have had little revenue since our inception. For the three months ended March 31, 2015, we incurred a net loss of approximately $645,000 and utilized $502,000 in cash flows from operating activities. We had cash on hand of approximately $42,000 as of March 31, 2015. Successful completion of our development program, implementation of our marketing strategy and transition to profitable operations is dependent upon obtaining additional financing until we are able to achieve a level of revenues adequate to support our cost structure. Many of our objectives to establish profitable business operations rely upon the occurrence of events outside our control; there is no assurance that we will be successful in accomplishing these objectives.
We have incurred operating losses, accumulated deficit and negative cash flows from operations since inception. As of March 31, 2015, we had an accumulated deficit of approximately $13,560,000.
Management anticipates that we will require substantial additional funds to continue operations. As of March 31, 2015, we had approximately $42,000 cash on hand and were spending approximately $220,000 per month, of which only a minor amount was satisfied by gross proceeds from operations. Hence, the amount of cash on hand is not adequate to meet our operating expenses over the next twelve months.
Financing Activities
On March 1, 2015, the Company closed its non-public equity offering at $1.75 per unit (the Units). Each Unit consisted of one common share and one-half warrant, with each whole warrant exercisable at $2.00 per share. The purchase price for the Units was payable in either cash, conversion of outstanding Series D preferred shares or certain outstanding promissory notes. For the three months ended March 31, 2015 the Company raised cash proceeds of $88,000 and issued 50,285 shares of common stock and warrants to purchase 25,141 shares of common stock as part of the private equity offering.
On February 16, 2015, the Company entered into a Senior secured loan agreement with JMW Fund, Richland Fund, and San Gabriel Fund (collectively, the lenders) whereby the lenders agreed to loan to the Company up to an aggregate of $2,000,000. The interest rate on the notes is 12% per annum and monthly interest payments are due the first day each month beginning March 1, 2015. The notes mature six months from the date of issuance. If any interest payment remains unpaid in excess of 90 days, and the lender has not declared the entire principal and unpaid accrued interest due and payable, the interest rate on that amount only will be increased to 18% per annum, until the past due interest amount is paid in full. The notes and any future notes under the loan agreement are secured by all of the assets of the Company, including intellectual property rights. Upon the occurrence of an event of default the lenders have the right to foreclose on the assets of the Company. During the three months ended March 31, 2015, the Company has issued notes with an aggregate principal amount of $470,000.
18
The Company received $80,000 in short-term unsecured notes in January 2015; which were converted on February 23, 2015 into senior secured notes payable under the $2 million loan agreement as described above, and included above in the aggregate principal amount. In addition, on February 23, 2015 the Company converted the outstanding $20,000 short-term unsecured note, entered into during December 2014, into a senior secured note payable under the $2 million loan agreement, included above in the aggregate principal amount. As of May 14, 2015 the Company issued notes for an additional $179,000 in relation to the $2,000,000 senior secured debt offering.
Based upon the Companys current financial position, the Company does not believe it will be able to satisfy the mandatory principal payments in 2015 under the $2,000,000 senior secured debt. The Company will work with the lenders to explore extension or conversion options. These notes are secured by all of the assets of the Company, including intellectual property rights. If the Company defaults on the loan payments the Companys assets may be foreclosed upon.
Cash Requirements
The issues described in the paragraphs above raise substantial doubt about our ability to continue as a going concern. We are solely reliant on raising additional capital in order to maintain our current operations. To date, we have been able to raise debt and equity financing through the assistance of a small number of our investors who have been substantial participants in our debt and equity offerings since our formation. If these investors choose not to assist us with our capital raising initiatives in the future, we do not expect that we would be able to obtain any alternative forms of financing at this time and we would not be able to continue to satisfy our current or long term obligations. Based upon our current monthly spend we anticipate the need to raise at least $2,600,000 to meet our cash flow requirements for the next twelve months.
Recent accounting pronouncements
There were no new accounting pronouncements issued during the three months ended March 31, 2015 that had a material impact or are anticipated to have a material impact on our financial position, cash flows or operating results.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As a smaller reporting company, we have elected not to provide the disclosure required by this item.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of disclosure controls and procedures
Our management, with the participation of our Chief Executive Officer, who also serves as our Chief Financial Officer, has concluded, based on evaluation, as of the end of the period covered by this report, that our disclosure controls and procedures (as defined in Rule 15d-15(e) under the Exchange Act) are (1) not effective to ensure that material information required to be disclosed by us in reports filed or submitted by us under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission due to the material weakness noted below, and (2) designed to ensure that material information required to be disclosed by us in such reports is accumulated, organized and communicated to our management, including our principal executive officer and principal financial officer, as appropriated, to allow timely decisions regarding required disclosure.
Material Weakness and Related Remediation Initiatives
Our CEO and CFO concluded the following material weaknesses existed: 1. Due to the Companys budget constraints, the Companys accounting department does not maintain the number of accounting personnel (either in-house or external) necessary to ensure more complete and effective financial reporting controls. Through the efforts of management, external consultants, and our Audit Committee, we have developed a specific action plan to remediate the material weaknesses. We expect to implement these various action plans during 2015. If we are able to complete these action plans in a timely manner, we anticipate that the material weakness will be remediated by December 31, 2015.
19
Changes in internal control over financial reporting
There has been no change in our internal control over financial reporting, as defined in Rules 13a-15(f) of the Exchange Act, during our most recent fiscal quarter ended March 31, 2015, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II - OTHER INFORMATION
ITEM 1A. RISK FACTORS
We are a voluntary filer and are not required to file Exchange Act reports going forward and may cease to file reports at any time and for any reason without notice.
On June 5, 2013 our S-1 registration statement became effective which meant we became subject to certain reporting obligations of the Exchange Act. Under Section 15(d) of the Exchange Act such an issuer is subject to the periodic and current reporting requirements of Section 13(a) of that Act. These reports would include Forms 10-K, 10-Q, and 8-K, but would not include items such as beneficial ownership reports and proxy statements. The reporting obligation for such an issuer is automatically suspended if the class of securities is held by fewer than 300 record holders at the beginning of any fiscal year (other than a year in which the registration statement became effective). Such an issuer then becomes a voluntary filer. A voluntary filer may continue to file periodic reports on a voluntary basis; however, it is not required to do so.
On January 1, 2015, we had fewer than 300 record holders and, thus, our reporting obligations were automatically suspended. As such, we became a voluntary filer. Although we have continued to file our Exchange Act reports and have no plans to cease filing Exchange Act reports, we may cease to file our Exchange Act reports at any time and for any reason without notice. As a result, less information may be publicly available than would be otherwise contained in our reports.
See Item 1A - Risk Factors as disclosed in Form 10-K as filed with the Securities and Exchange Commission on April 14, 2015.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
On March 13, 2015, we issue a total of 15,000 shares of common stock to a total of three individuals for services performed. These issuances were made pursuant to Regulation S promulgated by the Securities and Exchange Commission (the Commission) under the Securities Act of 1933, as amended (the Securities Act). The issuances were made in off-shore transactions as defined in Regulation S and there were no directed selling efforts made in the U.S. by us or any of our respective affiliates, or any person acting on behalf of any of the foregoing. Applicable offering restrictions were also implemented by us in compliance with Rule 903(b)(3) of Regulation S. Those who received the shares also agreed to conform to the restrictions on resale of the securities contained in Regulation S. No selling commissions were paid in connection with the share issuances.
ITEM 6. EXHIBITS
SEC Ref. No. | Title of Document |
31.1 | Rule 15d-14(a) Certification by Principal Executive Officer and Principal Financial Officer |
32.1 | Section 1350 Certification of Principal Executive Officer and Principal Financial Officer |
101.INS | XBRL Instance Document |
101.SCH | XBRL Taxonomy Extension Schema Document |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
20
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Heatwurx, Inc.
Date: May 15, 2015 | By | /s/ Heather Kearns |
|
| Heather Kearns, Interim Chief Executive Officer and Interim Chief Financial Officer |
|
| (Principal Executive Officer and Principal Financial and Accounting Officer) |
21